ArticleThe Journal of clinical endocrinology and metabolism2013

Mitochondria-targeted nitroxide, Mito-CP, suppresses medullary thyroid carcinoma cell survival in vitro and in vivo.

Dmytro Starenki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.